Reply
Runqiu Jiang, Chuanyong Zhang, Yongxiang Xia, Xiaofeng Qian, Xuehao Wang, Beicheng Sun – 10 July 2013
Statins for prevention of hepatocellular cancer: One step closer?
Siddharth Singh, Preet Paul Singh – 10 July 2013
Liver remnant volume after living donor liver transplantation: How low should we go?
- Read more about Liver remnant volume after living donor liver transplantation: How low should we go?
James J. Pomposelli – 9 July 2013
Endogenous signal transducer and activator of transcription 3 is required for the protection of hepatocytes against warm ischemia/reperfusion injury
Lucy Xi Lou, Tadahiro Uemura, Haresh Mani, Chen Yang, Weiyi Li, Zakiyah Kadry, Samuel Shao‐Min Zhang – 9 July 2013 – Warm ischemia/reperfusion (I/R) is a common clinical problem during liver transplantation and liver resection. Warm ischemia also occurs during trauma and shock. However, there is still no safe and promising strategy for protecting the liver from I/R injury. Signal transducer and activator of transcription 3 (STAT3) is a major immediate response molecule for protecting cell survival.
It is more than just size: Obesity and transplantation
Mark S. Orloff, M. Katherine Dokus – 9 July 2013
Long‐term medical management of the pediatric patient after liver transplantation: 2013 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
Deirdre A. Kelly, John C. Bucuvalas, Estella M. Alonso, Saul J. Karpen, Upton Allen, Michael Green, Douglas Farmer, Eyal Shemesh, Ruth A. McDonald – 9 July 2013
Segment 4 architecture and proposed parenchyma‐wise technique for Ex vivo graft procurement and implantation
Ramadan M. Gharbawy, Bakr M. Nour – 9 July 2013 – A parenchyma‐wise technique for the ex vivo procurement of segment 4 (S4) grafts, based on the detailed architecture of the segment, is proposed. Eighteen normal, fresh livers from adult cadavers were injected differentially with colored latex; dissection casts were prepared; and the intricate architecture of S4 was studied.
The insulin receptor translocates to the nucleus to regulate cell proliferation in liver
Maria J. Amaya, André G. Oliveira, Erika S. Guimarães, Marisa C.F. Casteluber, Sandhra M. Carvalho, Lidia M. Andrade, Mauro C.X. Pinto, Albert Mennone, Cleida A. Oliveira, Rodrigo R. Resende, Gustavo B. Menezes, Michael H. Nathanson, M. Fatima Leite – 9 July 2013 – Insulin's metabolic effects in the liver are widely appreciated, but insulin's ability to act as a hepatic mitogen is less well understood.
New frontier in liver cancer treatment: Oncolytic viral therapy
Sílvia Vilarinho, Tamar H. Taddei – 8 July 2013
Organized proteomic heterogeneity in colorectal cancer liver metastases and implications for therapies
Andrei Turtoi, Arnaud Blomme, Delphine Debois, Joan Somja, David Delvaux, Georgios Patsos, Emmanuel Valentin, Olivier Peulen, Eugène Nzaramba Mutijima, Edwin Pauw, Philippe Delvenne, Olivier Detry, Vincent Castronovo – 6 July 2013 – Tumor heterogeneity is a major obstacle for developing effective anticancer treatments. Recent studies have pointed to large stochastic genetic heterogeneity within cancer lesions, where no pattern seems to exist that would enable a more structured targeted therapy approach.